pSivida Corp. (NASDAQ:PSDV) rose 9.2% during trading on Tuesday . The stock traded as high as $3.67 and last traded at $3.67, with a volume of 128,175 shares traded. The stock had previously closed at $3.36.

Separately, FBR & Co restated a “buy” rating and issued a $7.00 price objective (up previously from $6.00) on shares of pSivida Corp. in a research report on Thursday, May 12th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. pSivida Corp. presently has an average rating of “Hold” and a consensus price target of $7.00.

The stock’s 50-day moving average price is $3.22 and its 200 day moving average price is $3.09. The firm’s market cap is $129.17 million.

pSivida Corp. (NASDAQ:PSDV) last posted its earnings results on Thursday, May 5th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.05. Equities research analysts expect that pSivida Corp. will post ($0.62) earnings per share for the current fiscal year.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.